Navigation Links
First Interim Analysis Of NW Bio's Phase III GBM Trial Triggered By Reaching Required Number Of "Events"
Date:12/10/2013

stage prostate cancer.

Disclaimer

Statements made in this news release that are not historical facts, including statements concerning future treatment of patients using DCVax and future clinical trials, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Words such as "expect," "believe," "intend," "plan," "continue," "may," "will," "anticipate," and similar expressions are intended to identify forward-looking statements.  Actual results may differ materially from those projected in any forward-looking statement.  Specifically, there are a number of important factors that could cause actual results to differ materially from those anticipated, such as the Company's ability to raise additional capital, risks related to the Company's ability to enroll patient s in its clinical trials and complete the trials on a timely basis, the uncertainty of the clinical trials process, uncertainties about the timely performance of third parties, and whether the Company's products will demonstrate safety and efficacy.  Additional information on these and other factors, including Risk Factors, which could affect the Company's results, is included in its Securities and Exchange Commission ("SEC") filings.  Finally, there may be other factors not mentioned above or included in the Company's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. You should not place undue reliance on any forward-looking statements. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.


'/>"/>
SOURCE Northwest Biotherapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Varian Medical Systems Schedules First Quarter FY2014 News Release and Conference Call
2. Henry Ford Hospital Performs First Minimally Invasive Laser Brain Surgeries in Michigan
3. Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
4. Heptares Initiates Clinical Study With First Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Patients With Alzheimers Disease
5. DesignRx Introduces The First Steps Program
6. Cantel Medical Reports 19% Sales Growth And EPS Of $0.27 vs. $0.23 For The First Quarter Ended October 31, 2013
7. The Approval Of The First Biosimilar Monoclonal Antibody In Europe Has Major Implications For 2014 And Beyond
8. Germany, Japan and Russia Will be the First Markets to Experience Peak Cases in Several Commercially Significant Drug Markets
9. VeriMed Introduces RADAR(SM): The First Patient Risk Assessment Empowering Pain Physicians To Identify Patients Who May Abuse Or Divert Prescription Drugs
10. NeuroPhage to Participate in Worlds First G8 Dementia Summit
11. MinuteClinic Opens First Clinic Locations in New Hampshire
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... About Vision Care Products ... this report are Rx lenses, frames, contact lenses, ... used by consumer for vision correction and vision ... contact lenses require a prescription for purchase while ... that can be purchased like any other apparel ...
(Date:9/3/2015)... Sept. 3, 2015 About ... that involves narrowing or blockage of blood vessels. ... problems, smoking, high cholesterol, and high blood pressure. ... atherosclerosis, and heart failure are some of the ... blood vessels, especially coronary arteries, is one of ...
(Date:9/3/2015)... PARK, Calif. , Sept. 3, 2015 ... device company that is providing innovative evidence-based solutions for ... management will be presenting at the Morgan Stanley Global ... York City.  Nevro management is scheduled ... be accessible via a live audio webcast, accessible in ...
Breaking Medicine Technology:Vision Care Market in the US 2015-2019 2Global Cardiovascular Implants Market 2015-2019 2
... Progress in SuperGen's,Oncology-Focused Pre-Clinical Pipeline, LOS ANGELES, ... announced that MP470, its multi-targeted tyrosine kinase,inhibitor, ... of,double- stranded DNA repair in cancer cells ... the 2007 American Association for Cancer Research,Annual ...
... - Abraxis BioScience,Inc. (NASDAQ:ABBI), an integrated, ... a pre-clinical study,evaluating the toxicity and ... mTOR kinase inhibitor, at the 98th,American ... Meeting held,April 14-18, 2007 in Los ...
Cached Medicine Technology:Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 2Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 3Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 4Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 5Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 6Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor,Suppresses Critical Double-Stranded DNA Repair Protein, Rad51 7Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 2Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 3Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 4
(Date:9/3/2015)... ... September 04, 2015 , ... AlignLife of Wauwatosa is excited ... are so many children and adults who don't have the ability to buy a ... love holding our annual Coat Drive to help those in need." , This is ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... , a privately held medical technology company that will bring low-cost cancer pre-screening ... worldwide. , Preora’s proprietary and automated technology platform detects and measures cellular ...
(Date:9/3/2015)... ... September 03, 2015 , ... The Beryl Institute announces ... to be held April 13-15 at Sheraton Hotel in Dallas, Texas. Patient Experience ... collective voices of healthcare leaders, staff, physicians, patients and families across the globe ...
(Date:9/3/2015)... RI (PRWEB) , ... September 03, 2015 , ... BedJet ... beds, the BedJet v2, for pre-order on Kickstarter. Today the BedJet v2 pre-order ... it in the top 0.1% most successful campaigns ever on crowdfunding giant Kickstarter. , ...
(Date:9/3/2015)... ... 2015 , ... Hope For The Warriors® is pleased to ... awarded two times each year to spouses or caregivers of post-9/11 wounded or ... restoring a sense of self, restoring the family unit, and restoring hope for ...
Breaking Medicine News(10 mins):Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 2Health News:Patient Experience Conference 2016 Program Announced by The Beryl Institute 3Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 2Health News:BedJet Hits $1 million in Sales in 28 Days on Kickstarter after Shark Tank Rejection 3Health News:Hope For The Warriors Spouse/Caregiver Scholarships Now Open for Spring 2016 2
... natural for a patient to tread carefully, fearing another ... emotions// after a heart attack, which cannot be wished ... to allay the doubts and uncertainties that ebb and ... ambiguous communication from caregivers cause more harm than good. ...
... direct, linear relationship between the sequence of a protein ... of DNA and protein sequences is thought to be ... a paper published today in Science by a team ... for Cancer Research (LICR) and the Seattle-based Fred Hutchinson ...
... high school, Katherine Coit had brain surgery to remove an ... brain.// ,The potentially life-threatening condition called arterio-venous malformation ... with numbness in her mouth and in one of her ... percent of the AVM during a craniotomy three years ago, ...
... many college students left the comforts of home to live ... from mom and dad may be great, but dorm-life// also ... that can be picked up in communal bathrooms/showers. “Shared showers ... bacteria because the wet, steamy atmosphere is a great place ...
... proposals to introduce picture warnings on tobacco packaging//. ... by smoking will help cut the number of people ... said today. ,Welsh Secretary of the ... Wales see the devastating effects caused by smoking. The ...
... Hopkins have linked a gene that allows for the chemical ... worms to the severe congestion and polyp formation typical of ... found that the gene for the enzyme, acidic mammalian chitinase ... with severe sinus inflammation that persists even after surgery when ...
Cached Medicine News:Health News:Protein Splicing Upsets the DNA Colinearity Paradigm 2Health News:Gamma Knife Offers Noninvasive Treatment for Vascular Disorders, Brain Tumors 2Health News:Gamma Knife Offers Noninvasive Treatment for Vascular Disorders, Brain Tumors 3Health News:Tips for Avoiding Foot Fungus in Communal Bathrooms 2Health News:Immune Response Linked to “Ghost” Parasites and Severely Congested Sinus 2Health News:Immune Response Linked to “Ghost” Parasites and Severely Congested Sinus 3Health News:Immune Response Linked to “Ghost” Parasites and Severely Congested Sinus 4
Inquire...
... Subcellular Fractionation, Proteins and Viruses ... rpm) with fixed-angle rotor • ... to 85 mL • Operating ... 40° C • Rotors certified ...
... is up to 10 inches/ 25 cm thinner than ... the Allegra X-22 Series is the space-saving multipurpose solution ... inches / 46 cm wide • 11 Rotor Library ... different ways to Spin 1.5 mL & PCR+ Tubes: ...
... The compact Allegra X-22 Series is up to 10 ... a library of 11 rotors, the Allegra X-22 Series ... Features: Only 18 inches / 46 cm ... 22,065 x g 3 different ways to Spin ...
Medicine Products: